KIN - Kindred Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5262.11M
Enterprise Value 3174.95M
Trailing P/E N/A
Forward P/E 1-5.65
PEG Ratio (5 yr expected) 1-0.11
Price/Sales (ttm)105.65
Price/Book (mrq)2.17
Enterprise Value/Revenue 370.52
Enterprise Value/EBITDA 6-3.10

Trading Information

Stock Price History

Beta (3Y Monthly) 0.25
52-Week Change 3-46.38%
S&P500 52-Week Change 36.42%
52 Week High 315.75
52 Week Low 36.62
50-Day Moving Average 38.04
200-Day Moving Average 39.26

Share Statistics

Avg Vol (3 month) 3165.11k
Avg Vol (10 day) 3195.72k
Shares Outstanding 528.2M
Float 29.97M
% Held by Insiders 15.87%
% Held by Institutions 157.25%
Shares Short (Jun 28, 2019) 41.04M
Short Ratio (Jun 28, 2019) 46.83
Short % of Float (Jun 28, 2019) 43.49%
Short % of Shares Outstanding (Jun 28, 2019) 42.68%
Shares Short (prior month May 31, 2019) 4860.97k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,323.18%

Management Effectiveness

Return on Assets (ttm)-33.85%
Return on Equity (ttm)-56.78%

Income Statement

Revenue (ttm)2.48M
Revenue Per Share (ttm)0.07
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)1.64M
EBITDA -56.48M
Net Income Avi to Common (ttm)-55.77M
Diluted EPS (ttm)-1.67
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)95.99M
Total Cash Per Share (mrq)2.46
Total Debt (mrq)1.8M
Total Debt/Equity (mrq)1.50
Current Ratio (mrq)9.10
Book Value Per Share (mrq)3.09

Cash Flow Statement

Operating Cash Flow (ttm)-52.47M
Levered Free Cash Flow (ttm)-43.07M